Biomerica, Inc. (BMRA) Social Stream



Biomerica, Inc. (BMRA): $0.37

0.02 (+4.51%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

C

BIOMERICA INC (BMRA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering BIOMERICA INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-04-20 1 $9.5 $9.5 $9.5 $1.072 786.19%
2022-01-14 1 $13 $9.5 $11.25 $1.072 949.44%
2022-03-22 1 $13.001 $9.5 $11.25 $1.072 949.44%

Price Target Last Issued March 22, 2022

The Trend in the Analyst Price Target


Over the past 38 weeks, BMRA's average price target has gone up $0.37.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential

BMRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 0 1 0 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how BIOMERICA INC fares relative to all US stocks, note that its number of analysts covering the stock is higher than nearly none of that group.
  • BIOMERICA INC's upside potential (average analyst target price relative to current price) is greater than 388.2% of all US stocks.
  • To contextualize these metrics, consider that out of Healthcare stocks, BIOMERICA INC's variance in analysts' estimates is lower than 52.35% of them.
  • In terms of how BIOMERICA INC fares relative to Medical Equipment stocks, note that its average analyst price target is greater than 57.47% of that group.

Stocks similar to BIOMERICA INC in the Medical Equipment industry regarding analyst recommendations and price targets are CHEK, MOVE, and PYPD.

Is BMRA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!